[HTML][HTML] Clinically-relevant ABC transporter for anti-cancer drug resistance

H Xiao, Y Zheng, L Ma, L Tian, Q Sun - Frontiers in pharmacology, 2021 - frontiersin.org
Multiple drug resistance (MDR), referring to the resistance of cancer cells to a broad
spectrum of structurally and mechanistically unrelated drugs across membranes, severely …

[HTML][HTML] Drug-resistant epilepsy: multiple hypotheses, few answers

F Tang, AMS Hartz, B Bauer - Frontiers in neurology, 2017 - frontiersin.org
Epilepsy is a common neurological disorder that affects over 70 million people worldwide.
Despite the recent introduction of new antiseizure drugs (ASDs), about one-third of patients …

[HTML][HTML] ABC transporters in cancer stem cells: beyond chemoresistance

RR Begicevic, M Falasca - International journal of molecular sciences, 2017 - mdpi.com
The efficacy of chemotherapy is one of the main challenges in cancer treatment and one of
the major obstacles to overcome in achieving lasting remission and a definitive cure in …

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade

Z Chen, T Shi, L Zhang, P Zhu, M Deng, C Huang, T Hu… - Cancer letters, 2016 - Elsevier
Multidrug resistance (MDR) is a serious phenomenon employed by cancer cells which
hampers the success of cancer pharmacotherapy. One of the common mechanisms of MDR …

A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention

AY Chen, YC Chen - Food chemistry, 2013 - Elsevier
Kaempferol is a polyphenol antioxidant found in fruits and vegetables. Many studies have
described the beneficial effects of dietary kaempferol in reducing the risk of chronic …

[HTML][HTML] Drug resistance in metastatic breast cancer: tumor targeted nanomedicine to the rescue

V Gote, AR Nookala, PK Bolla, D Pal - International journal of molecular …, 2021 - mdpi.com
Breast cancer, specifically metastatic breast, is a leading cause of morbidity and mortality in
women. This is mainly due to relapse and reoccurrence of tumor. The primary reason for …

Antibody–drug conjugates as novel anti-cancer chemotherapeutics

C Peters, S Brown - Bioscience reports, 2015 - portlandpress.com
Over the past couple of decades, antibody–drug conjugates (ADCs) have revolutionized the
field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues …

[HTML][HTML] Cancer stem cells and targeting strategies

L Barbato, M Bocchetti, A Di Biase, T Regad - Cells, 2019 - mdpi.com
Chemoresistance is a major problem in cancer therapy as cancer cells develop mechanisms
that counteract the effect of chemotherapeutic compounds, leading to relapse and the …

Xenobiotic, bile acid, and cholesterol transporters: function and regulation

CD Klaassen, LM Aleksunes - Pharmacological reviews, 2010 - ASPET
Transporters influence the disposition of chemicals within the body by participating in
absorption, distribution, and elimination. Transporters of the solute carrier family (SLC) …

Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents

GL Beretta, G Cassinelli, M Pennati, V Zuco… - European journal of …, 2017 - Elsevier
Resistance to conventional and target specific antitumor drugs still remains one of the major
cause of treatment failure and patience death. This condition often involves ATP-binding …